Contrary to the variability seen with fusion, impaired MERCs and reduced mitochondrial motility seem to be consistent features observed with MFN2 variants, suggesting that these dysfunctions contribute to the peripheral neuropathy phenotype that is the hallmark of CMT2A. The gene discussed is MFN2; the disease is peripheral neuropathy.